TScan Therapeutics Ownership | Who Owns TScan Therapeutics?
TScan Therapeutics Ownership Summary
TScan Therapeutics is owned by 24.99% institutional investors, 0.20% insiders, and 74.81% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 6.17% of TCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.50% of its assets in TScan Therapeutics shares.
TCRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | TScan Therapeutics | 24.99% | 0.20% | 74.81% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Lynx1 capital management lp | 8.02M | 6.17% | $8.10M |
| Blackrock | 4.46M | 4.70% | $26.10M |
| Bvf inc/il | 5.56M | 4.28% | $5.62M |
| Ecor1 capital | 5.00M | 4.21% | $15.20M |
| Baker bros. advisors lp | 2.78M | 2.14% | $2.81M |
| Vanguard group | 2.48M | 1.91% | $2.48M |
| Blackrock funding, inc. /de | 1.84M | 1.42% | $1.86M |
| Millennium management | 1.46M | 1.12% | $1.47M |
| Renaissance | 1.36M | 1.05% | $1.38M |
| Deer management | 1.25M | 0.96% | $1.26M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Dc funds, lp | 630.00K | 42.40% | $630.00K |
| Lynx1 capital management lp | 8.02M | 1.28% | $8.10M |
| Ecor1 capital | 5.00M | 0.57% | $15.20M |
| Deer management | 1.25M | 0.20% | $1.26M |
| Bvf inc/il | 5.56M | 0.18% | $5.62M |
| Verdad advisers, lp | 134.00K | 0.15% | $135.34K |
| Militia capital partners, lp | 102.10K | 0.09% | $185.82K |
| Dc investments management | 35.56K | 0.03% | $64.72K |
| Gsa capital partners llp | 378.96K | 0.02% | $383.00K |
| Baker bros. advisors lp | 2.78M | 0.02% | $2.81M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 4.46M | 0.00% | 2.76M |
| Millennium management | 1.46M | 0.00% | 1.06M |
| Jacobs levy equity management | 808.36K | 0.00% | 620.20K |
| Two sigma investments, lp | 1.21M | 0.00% | 557.83K |
| Bvf inc/il | 5.56M | 0.18% | 338.22K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | - | - | -3.50M |
| Checkpoint capital | - | - | -2.02M |
| Propel bio management | - | - | -1.93M |
| Alphabet | - | - | -1.08M |
| Great point partners | - | - | -1.02M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vanguard fiduciary trust | 305.77K | 0.00% | 305.77K | $308.83K |
| Verdad advisers, lp | 134.00K | 0.15% | 134.00K | $135.34K |
| Kestra advisory services | 62.52K | 0.00% | 62.52K | $63.15K |
| Ameriprise financial | 52.63K | - | 52.63K | $53.16K |
| Voleon capital management lp | 47.88K | 0.00% | 47.88K | $87.14K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -7.00 |
| Northwestern mutual wealth management | -8.00 |
| True wealth design | -9.00 |
| Eversource wealth advisors | -65.00 |
| Rothschild investment | -110.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 58 | -3.33% | 32,468,312 | 5.78% | 24 | 4.47% | 26 | -3.70% | 19 | 5.56% |
| Dec 31, 2025 | 34 | -52.78% | 10,292,013 | -70.26% | 7 | 1.11% | 18 | -28.00% | 9 | -67.86% |
| Sep 30, 2025 | 72 | -4.00% | 34,601,233 | 1.17% | 26 | 3.84% | 25 | -41.86% | 28 | 64.71% |
| Jun 30, 2025 | 78 | -12.36% | 35,711,883 | -7.86% | 27 | 3.08% | 46 | -6.12% | 17 | -5.56% |
| Mar 31, 2025 | 92 | 4.55% | 40,135,892 | -3.36% | 30 | 2.53% | 50 | 6.38% | 19 | 18.75% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 1.50M | 2.50% | - |
| Simplify Propel Opportunities ETF | 1.05M | 1.84% | - |
| abrdn Life Sciences Investors | 836.78K | 1.47% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 577.59K | 0.96% | - |
| BlackRock Health Sciences Opps Inv A | 556.65K | 0.93% | - |
| Invesco Dorsey Wright SmallCap Momt ETF | 475.53K | 0.90% | - |
| BlackRock Health Sciences Term Trust | 407.01K | 0.72% | -638.76K |
| Fidelity Small Cap Index | 392.73K | 0.69% | - |
| Fidelity Extended Market Index | 319.69K | 0.53% | 48.25K |
| iShares Biotechnology ETF | 262.48K | 0.46% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 19, 2025 | Lynx1 Capital Management LP | - | Buy | $71.97K |
| Dec 23, 2025 | Lynx1 Capital Management LP | - | Buy | $5.60K |
| Dec 22, 2025 | Lynx1 Capital Management LP | - | Buy | $67.95K |
| May 20, 2025 | Lynx1 Capital Management LP | - | Buy | $1.44M |
| May 19, 2025 | Lynx1 Capital Management LP | - | Buy | $1.67M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | - |
| 2026 Q1 | - | - |
| 2025 Q4 | 3 | - |
| 2025 Q3 | - | - |
| 2025 Q2 | 2 | - |
TCRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools